These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34244734)

  • 21. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study.
    Petersson J; Åkesson K; Sundberg F; Särnblad S
    Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Glycemic Control Improvement After the Home and Self-Care Program for Patients With Type 1 Diabetes: Real-World-Based Cohort Study.
    Koo DJ; Moon SJ; Moon S; Park SE; Rhee EJ; Lee WY; Park CY
    J Med Internet Res; 2024 Sep; 26():e60023. PubMed ID: 39259960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.
    Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R;
    Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
    Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
    J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 31. The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population.
    Vandenbempt M; Matheussen H; Charleer S; Rochtus A; Casteels K
    Diabetes Technol Ther; 2024 May; 26(5):346-350. PubMed ID: 38133644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic control assessed by continuous glucose monitoring during pregnancy in women with type 1 diabetes and its association with preeclampsia, an observational Swedish cohort study.
    Englund Ögge L; Dotevall A; Elfvin A; Sandgren U; Linden K; Bohlin L; Wallstersson B; Sjödell M; Augustinsson J; Hagman A
    Acta Obstet Gynecol Scand; 2024 Jul; 103(7):1426-1436. PubMed ID: 38725185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
    Voormolen DN; DeVries JH; Sanson RME; Heringa MP; de Valk HW; Kok M; van Loon AJ; Hoogenberg K; Bekedam DJ; Brouwer TCB; Porath M; Erdtsieck RJ; NijBijvank B; Kip H; van der Heijden OWH; Elving LD; Hermsen BB; Potter van Loon BJ; Rijnders RJP; Jansen HJ; Langenveld J; Akerboom BMC; Kiewiet RM; Naaktgeboren CA; Mol BWJ; Franx A; Evers IM
    Diabetes Obes Metab; 2018 Aug; 20(8):1894-1902. PubMed ID: 29603547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
    Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER
    Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous Glucose Monitoring Metrics for Pregnancies Complicated by Diabetes: Critical Appraisal of Current Evidence.
    Szmuilowicz ED; Barbour L; Brown FM; Durnwald C; Feig DS; O'Malley G; Polsky S; Aleppo G
    J Diabetes Sci Technol; 2024 Jul; 18(4):819-834. PubMed ID: 38606830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    Polsky S; Garcetti R; Pyle L; Joshee P; Demmitt JK; Snell-Bergeon JK
    PLoS One; 2020; 15(4):e0230476. PubMed ID: 32298269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009613. PubMed ID: 24782359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.